HCW Biologics Inc. Annual Cost of Revenue in USD from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
HCW Biologics Inc. quarterly/annual Cost of Revenue history and growth rate from 2021 to 2024.
  • HCW Biologics Inc. Cost of Revenue for the quarter ending December 31, 2024 was $316K, a 70.5% decline year-over-year.
  • HCW Biologics Inc. Cost of Revenue for the twelve months ending December 31, 2024 was $1.61M, a 29.5% decline year-over-year.
  • HCW Biologics Inc. annual Cost of Revenue for 2024 was $1.61M, a 29.5% decline from 2023.
  • HCW Biologics Inc. annual Cost of Revenue for 2023 was $2.28M, a 44.8% decline from 2022.
  • HCW Biologics Inc. annual Cost of Revenue for 2022 was $4.14M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.61M -$674K -29.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $2.28M -$1.85M -44.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 $4.14M +$4.14M Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-15
2021 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.